Omni-Wave^™ hydrogel-free biosensing technology.

Omni-Wave™ passes ISO 10993-10 for sensitization and irritation.
AAMI compliant.
It has been awarded more than 90 patents worldwide and is ready to change the electrode paradigm.

For additional information on research conducted regarding this technology contact us today.

Papers:

Case Study:

Gen-4 Flexcon® Omni-Wave™ 3-day clinical study done at
University of Massachusetts Memorial Hospital